Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 μg once daily, for the treatment of seasonal allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 6, 2010, Pages 471-479

  Ratner, Paul ^a   Jacobs, Robert ^b   Mohar, Dale ^c   Huang, Holly ^d   Desai, Shailesh Y ^d   Hinkle, Joseph ^d  

^a Sylvana Research   (United States)

^b Biogenics Research Institute   (United States)

^c Kerrville Research Associates   (United States)

^d DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CICLESONIDE; PLACEBO;

ADULT; ARTICLE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; GASTROESOPHAGEAL REFLUX; HAY FEVER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NASAL DISCOMFORT; NASAL SEPTUM DISORDER; NOSE DISEASE; PAPULAR RASH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AEROSOL PROPELLANTS; AGED; ANTI-ALLERGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMPOUNDING; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; MALE; MIDDLE AGED; NASAL SPRAYS; PREGNENEDIONES; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; UNITED STATES;

EID: 78649910331     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.09.024     Document Type: Article

References (21)

1. M. Schatz A survey of the burden of allergic rhinitis in the USA Allergy 62 suppl 85 2007 9 16
2. R.A. Nathan The burden of allergic rhinitis Allergy Asthma Proc 28 2007 3 9
3. W.W. Storms Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis J Allergy Clin Immunol 114 suppl 2004 S146 S153
4. D.P. Skoner Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis J Allergy Clin Immunol 108 2001 S2 S8
5. D.V. Wallace, M.S. Dykewicz, and D.I. Bernstein The diagnosis and management of rhinitis: an updated practice parameter J Allergy Clin Immunol 122 suppl 2008 S1 S84
6. E. Mutch, R. Nave, N. McCracken, K. Zech, and F.M. Williams The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue Biochem Pharmacol 73 2007 1657 1664
7. P.H. Ratner, M.A. Wingertzahn, J.H. van Bavel, F. Hampel, P.F. Darken, and T. Shah Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis J Allergy Clin Immunol 118 2006 1142 1148 (Pubitemid 44755181)
8. E.O. Meltzer, S. Kunjibettu, and N. Hall Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis Ann Allergy Asthma Immunol 98 2007 175 181 (Pubitemid 46214225)
9. Omnaris [package insert] 2007 Sepracor Inc Marlborough, MA
10. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects 2008 World Medical Association Ferney-Voltaire, France
11. A. Dmitrienko, B.L. Wiens, A.C. Tamhane, and X. Wang Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives Stat Med 26 2007 2465 2478
12. B.G. Martin, P.H. Ratner, and F.C. Hampel Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents Allergy Asthma Proc 28 2007 216 225
13. H.B. Kaiser, R.M. Naclerio, J. Given, T.N. Toler, A. Ellsworth, and E.E. Philpot Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis J Allergy Clin Immunol 119 2007 1430 1437 (Pubitemid 46855849)
14. C.P. Andrews, B.G. Martin, and R.L. Jacobs Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy Allergy Asthma Proc 30 2009 128 138
15. W.J. Fokkens, R. Jogi, and S. Reinartz Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen Allergy 62 2007 1078 1084
16. R. Jacobs, B. Martin, F. Hampel, W. Toler, A. Ellsworth, and E. Philpot Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen Curr Med Res Opin 25 2009 1393 1401
17. D.I. Bernstein, A.L. Levy, and F.C. Hampel Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis Clin Exp Allergy 34 2004 952 957
18. G. Ciprandi, W.G. Canonica, M. Grosclaude, J. Ostinelli, G.G. Brazzola, and J. Bousquet Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis Allergy 57 2002 586 591
19. G. Settipane, P.E. Korenblat, and J. Winder Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study Clin Ther 17 1995 252 263
20. R. Nave, R. Herzog, A. Laurent, and M.A. Wingertzahn Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers Clin Ther 31 2009 2988 2999
21. C. LaForce, J. van Bavel, E.O. Meltzer, and M.A. Wingertzahn Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis Ann Allergy Asthma Immunol 103 2009 166 173